PAFAH1B2 and breast neoplasm: In line with our findings, PAFAH1B2 was no significantly upregulated in human breast tumors, but targeting PAFAH1B2 could also significantly impaired proliferation, survival, migration, and invasiveness in breast cancer cells (34).